Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 23 June 2022




EFPIA welcomes the launch of the EU NCDs Initiative
23 June 2022

The EU NCDs Initiative shows renewed political attention to NCDs and delivers a broad, integrated policy response across... Read more

EFPIA statement on the establishment of the HTA Coordination Group
22 June 2022

Europe has a unique opportunity to enact real step change in how it can attract and bring innovation to patients Read more

EFPIA and Vaccines Europe are deeply disappointed about the decision taken by World Trade Organization...
17 June 2022

The decision is a serious retrograde step in our collective ability to tackle the COVID-19 pandemic and future global... Read more




The EFPIA Disclosure: Where are we for the 7th publication?
23 June 2022 - Julie Bonhomme

In the context of increasing societal expectations on transparency, the disclosure requirements seek to address any... Read more

Cancer care for women: Why we must continue to strive for equal access (Guest blog)
23 June 2022 - Berfu Yaziyurt

For cancer patients to live fuller, healthier and more informed lifestyles, it is vital that we work together to bridge... Read more

Elevating the experience of men with cancer (Guest blog)
23 June 2022 - Jacqueline Daly

To mark #MensHealthMonth, Jacqueline Daly, member of the Let’s Talk Prostate Cancer (LTPC) Expert Group and co-founder... Read more

Supply Chains reshaping - How to respond to a crisis
23 June 2022 - Marco Farinelli - François Lamérant

#RegulatoryRoadtoInnovation Read more

5 ways to tackle Europe’s diabetes crisis
22 June 2022 - Maurizio Guidi - Elvera Laanen Larsen

Better data, action on inequality, and health system reforms are vital Read more

Maximising the EHDS impact on better health data sharing
20 June 2022 - Chris Walker

Sharing data from one or several individuals can help treat, cure, or save another Read more


EFPIA Conference | 29 June 2022

Register to join in person or online.


What we are reading


We must seize this opportunity, says EFPIA Director General Nathalie Moll
On 20 June 2022 (Hospimed)

"We have revolutionary biotech treatments and we try to fit them into existing healthcare systems built for chronic... Read more

EU Project Findings To ‘Instil Confidence’ In Using Patient Preference Studies
On 16 June 2022 (Pink Sheet)

The EMA’s endorsement of a framework that explains how drug and medical device sponsors can use patient preference studies... Read more

We’re already ignoring the next pandemic
On 07 June 2022 (Harvard Public Health)

Superbugs kill more than a million people annually. What are policymakers waiting on? Read more